NDC 69036-110

LORTUSS LQ

Doxylamine Succinate, Pseudoephedrine Hydrochloride

LORTUSS LQ is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sallus Laboratories, Llc. The primary component is Doxylamine Succinate; Pseudoephedrine Hydrochloride.

• Product ID: 69036-110_67df3c55-a2b0-4185-8a0d-18754cdae920
• NDC: 69036-110
• Product Type: Human Otc Drug
• Proprietary Name: LORTUSS LQ
• Generic Name: Doxylamine Succinate, Pseudoephedrine Hydrochloride
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2014-08-01
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Sallus Laboratories, LLC
• Substance Name: DOXYLAMINE SUCCINATE; PSEUDOEPHEDRINE HYDROCHLORIDE
• Active Ingredient Strength: 6 mg/5mL; mg/5mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 69036-110-16

473 mL in 1 BOTTLE (69036-110-16)

• Marketing Start Date: 2014-08-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69036-110-16 [69036011016]

LORTUSS LQ LIQUID

• Marketing Category: OTC MONOGRAPH FINAL
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-08-01
• Marketing End Date: 2019-12-31
• Inactivation Date: 2019-11-27
• Reactivation Date: 2020-05-13

Drug Details

Active Ingredients

Ingredient	Strength
DOXYLAMINE SUCCINATE	6.25 mg/5mL

OpenFDA Data

• SPL SET ID: cf3b8d12-8cba-433b-8cfb-93760dfa47e2
• Manufacturer:
  • Sallus Laboratories, LLC
• UNII:
  • V9BI9B5YI2
  • 6V9V2RYJ8N
• RxNorm Concept Unique ID - RxCUI:
  • 1094355

NDC Crossover Matching brand name "LORTUSS LQ" or generic name "Doxylamine Succinate, Pseudoephedrine Hydrochloride"

NDC	Brand Name	Generic Name
69036-110	LORTUSS LQ	Doxylamine Succinate, Pseudoephedrine Hydrochloride
70868-750	LORTUSS LQ	Doxylamine Succinate, Pseudoephedrine Hydrochloride